「Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis」の関連論文
-
Evaluation of Time to Failure of Strategy as an Alternative Surrogate Endpoint in Lung Cancer Patients with EGFR Mutations.
-
膠芽腫におけるPIK3CA遺伝子変異の臨床的意義についての考察
-
Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C : Results from LC-SCRUM-Asia study
-
Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors
-
Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
-
Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion
-
EGFR-TKI耐性と腫瘍内組織免疫微小環境との相互作用についての検討
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
-
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
-
非小細胞肺がん患者におけるオシメルチニブ有害事象とSTAT3, CYP3A5, ABCG2遺伝子多型との関連
-
ニボルマブによる治療を行った転移性腎細胞癌患者における血清中可溶性PD-L1の予後予測効果
-
Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR
-
Expression of programmed cell death ligand-1 by immune cells in the microenvironment is a favorable prognostic factor for primary diffuse large B-cell lymphoma of the central nervous system
-
Epidemiology of Japanese patients with atypical hemolytic uremic syndrome, and characteristics of patients with anti-CFH antibodies
-
<学会抄録>第70回日本泌尿器科学会中部総会
-
Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma
-
Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma
-
転移または再発乳癌の末梢血循環DNA変異解析の検討
-
Clinical significance of topoisomerase-II expression in patients with advanced Non-Small Cell Lung Cancer treated with amrubicin
-
頭頸部扁平上皮癌における遺伝子変異と蛋白表現型によるp53機能分類
-
A multicenter, open‑label, single‑arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
-
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09)
-
Optimized radiotherapy treatment strategy for early glottic carcinoma
-
膵癌における腫瘍浸潤リンパ球と患者の生存に関連した三次リンパ組織の統合分析
-
Analysis of radiotherapy-induced alterations of CD8+ T cells and PD-L1 expression in patients with uterine cervical squamous cell carcinoma
-
Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma : A Reappraisal of 23 Japanese Patients Based on EBV Association and PD-L1 Expression in Tumor Cells
-
Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer
-
癌患者ゲノミクスデータ解析を基盤とした乳癌幹細胞性維持機構の解明
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
原発性膠芽腫におけるTERTプロモーター領域遺伝子変異の臨床的・病理学的意義
-
Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
-
Prognostic value of somatic mutations at remission in acute myeloid leukemia
-
癌幹細胞マーカーが、食道扁平上皮癌における術前化学療法の抵抗性を予測する
-
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
-
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
-
Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial
-
Occult synchronous liver metastasis from perihilar cholangiocarcinoma
-
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer
-
The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy
-
The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis
-
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue
-
Long-Term Prognostic Predictors of Esophageal Squamous Cell Carcinoma Potentially Indicated for Endoscopic Submucosal Dissection
-
Comparing incidences of infusion site reactions between brand-name and generic vinorelbine in patients with non-small cell lung cancer
-
神経膠腫の再発・悪性転化に伴うネオアンチゲン発現変化と免疫応答変動の解析
-
初発単発肝細胞癌に対する肝切除と粒子線治療成績の比較:2施設間での傾向スコアマッチング解析を用いた検討
-
Phase II study of nab-paclitaxel plus cyclophosphamide plus trastuzumab neoadjuvant chemotherapy in early HER-2-positive breast cancer
-
転移・浸潤に関わるタンパク質Rho, ROCKの発現と、同時化学放射線療法後の子宮頸癌の予後との関係について
-
視床高悪性度神経膠腫摘出例におけるヒストン変異およびTERT promoter変異と生存予後に関する研究